vs
Natera, Inc.（NTRA）与泰瑞达（TER）财务数据对比。点击上方公司名可切换其他公司
泰瑞达的季度营收约是Natera, Inc.的1.6倍（$1.1B vs $665.5M），泰瑞达净利率更高（23.7% vs 7.1%，领先16.6%），泰瑞达同比增速更快（43.9% vs 39.8%），泰瑞达自由现金流更多（$218.8M vs $37.8M），过去两年Natera, Inc.的营收复合增速更高（34.5% vs 34.4%）
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
泰瑞达是总部位于美国马萨诸塞州北雷丁的自动测试设备（ATE）设计及制造企业，在全球半导体测试领域拥有深厚技术积累，服务的知名客户涵盖三星、高通、英特尔、亚德诺、德州仪器、IBM等行业头部企业。
NTRA vs TER — 直观对比
营收规模更大
TER
是对方的1.6倍
$665.5M
营收增速更快
TER
高出4.1%
39.8%
净利率更高
TER
高出16.6%
7.1%
自由现金流更多
TER
多$180.9M
$37.8M
两年增速更快
NTRA
近两年复合增速
34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $665.5M | $1.1B |
| 净利润 | $47.3M | $257.2M |
| 毛利率 | — | 57.2% |
| 营业利润率 | -3.4% | 27.1% |
| 净利率 | 7.1% | 23.7% |
| 营收同比 | 39.8% | 43.9% |
| 净利润同比 | 187.9% | 75.9% |
| 每股收益（稀释后） | $0.36 | $1.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTRATER
| Q4 25 | $665.5M | $1.1B | ||
| Q3 25 | $592.2M | $769.2M | ||
| Q2 25 | $546.6M | $651.8M | ||
| Q1 25 | $501.8M | $685.7M | ||
| Q4 24 | $476.1M | $752.9M | ||
| Q3 24 | $439.8M | $737.3M | ||
| Q2 24 | $413.4M | $729.9M | ||
| Q1 24 | $367.7M | $599.8M |
净利润NTRATER
| Q4 25 | $47.3M | $257.2M | ||
| Q3 25 | $-87.5M | $119.6M | ||
| Q2 25 | $-100.9M | $78.4M | ||
| Q1 25 | $-66.9M | $98.9M | ||
| Q4 24 | $-53.8M | $146.3M | ||
| Q3 24 | $-31.6M | $145.6M | ||
| Q2 24 | $-37.5M | $186.3M | ||
| Q1 24 | $-67.6M | $64.2M |
毛利率NTRATER
| Q4 25 | — | 57.2% | ||
| Q3 25 | — | 58.4% | ||
| Q2 25 | — | 57.2% | ||
| Q1 25 | — | 60.6% | ||
| Q4 24 | — | 59.4% | ||
| Q3 24 | — | 59.2% | ||
| Q2 24 | — | 58.3% | ||
| Q1 24 | — | 56.6% |
营业利润率NTRATER
| Q4 25 | -3.4% | 27.1% | ||
| Q3 25 | -16.5% | 18.9% | ||
| Q2 25 | -20.2% | 13.9% | ||
| Q1 25 | -15.8% | 17.6% | ||
| Q4 24 | -13.6% | 20.4% | ||
| Q3 24 | -8.9% | 20.6% | ||
| Q2 24 | -10.6% | 28.8% | ||
| Q1 24 | -20.2% | 13.0% |
净利率NTRATER
| Q4 25 | 7.1% | 23.7% | ||
| Q3 25 | -14.8% | 15.5% | ||
| Q2 25 | -18.5% | 12.0% | ||
| Q1 25 | -13.3% | 14.4% | ||
| Q4 24 | -11.3% | 19.4% | ||
| Q3 24 | -7.2% | 19.8% | ||
| Q2 24 | -9.1% | 25.5% | ||
| Q1 24 | -18.4% | 10.7% |
每股收益（稀释后）NTRATER
| Q4 25 | $0.36 | $1.62 | ||
| Q3 25 | $-0.64 | $0.75 | ||
| Q2 25 | $-0.74 | $0.49 | ||
| Q1 25 | $-0.50 | $0.61 | ||
| Q4 24 | $-0.41 | $0.89 | ||
| Q3 24 | $-0.26 | $0.89 | ||
| Q2 24 | $-0.30 | $1.14 | ||
| Q1 24 | $-0.56 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $293.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.7B | $2.8B |
| 总资产 | $2.4B | $4.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NTRATER
| Q4 25 | — | $293.8M | ||
| Q3 25 | $1.0M | $272.7M | ||
| Q2 25 | $16.0M | $339.3M | ||
| Q1 25 | $17.8M | $475.6M | ||
| Q4 24 | $22.7M | $553.4M | ||
| Q3 24 | $29.5M | $510.0M | ||
| Q2 24 | $90.3M | $421.9M | ||
| Q1 24 | $69.1M | $707.4M |
股东权益NTRATER
| Q4 25 | $1.7B | $2.8B | ||
| Q3 25 | $1.3B | $2.7B | ||
| Q2 25 | $1.2B | $2.8B | ||
| Q1 25 | $1.2B | $2.8B | ||
| Q4 24 | $1.2B | $2.8B | ||
| Q3 24 | $878.5M | $2.9B | ||
| Q2 24 | $836.5M | $2.7B | ||
| Q1 24 | $794.1M | $2.6B |
总资产NTRATER
| Q4 25 | $2.4B | $4.2B | ||
| Q3 25 | $1.8B | $4.0B | ||
| Q2 25 | $1.8B | $3.8B | ||
| Q1 25 | $1.7B | $3.7B | ||
| Q4 24 | $1.7B | $3.7B | ||
| Q3 24 | $1.6B | $3.8B | ||
| Q2 24 | $1.5B | $3.6B | ||
| Q1 24 | $1.5B | $3.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.9M | $281.6M |
| 自由现金流经营现金流 - 资本支出 | $37.8M | $218.8M |
| 自由现金流率自由现金流/营收 | 5.7% | 20.2% |
| 资本支出强度资本支出/营收 | 5.4% | 5.8% |
| 现金转化率经营现金流/净利润 | 1.56× | 1.09× |
| 过去12个月自由现金流最近4个季度 | $109.1M | $450.4M |
8季度趋势，按日历期对齐
经营现金流NTRATER
| Q4 25 | $73.9M | $281.6M | ||
| Q3 25 | $59.4M | $49.0M | ||
| Q2 25 | $37.6M | $182.1M | ||
| Q1 25 | $44.5M | $161.6M | ||
| Q4 24 | $52.9M | $282.6M | ||
| Q3 24 | $51.8M | $166.3M | ||
| Q2 24 | $4.0M | $216.1M | ||
| Q1 24 | $27.0M | $7.3M |
自由现金流NTRATER
| Q4 25 | $37.8M | $218.8M | ||
| Q3 25 | $37.0M | $2.4M | ||
| Q2 25 | $11.7M | $131.7M | ||
| Q1 25 | $22.6M | $97.6M | ||
| Q4 24 | $34.8M | $225.2M | ||
| Q3 24 | $35.5M | $114.4M | ||
| Q2 24 | $-7.7M | $171.2M | ||
| Q1 24 | $6.7M | $-36.7M |
自由现金流率NTRATER
| Q4 25 | 5.7% | 20.2% | ||
| Q3 25 | 6.2% | 0.3% | ||
| Q2 25 | 2.1% | 20.2% | ||
| Q1 25 | 4.5% | 14.2% | ||
| Q4 24 | 7.3% | 29.9% | ||
| Q3 24 | 8.1% | 15.5% | ||
| Q2 24 | -1.9% | 23.5% | ||
| Q1 24 | 1.8% | -6.1% |
资本支出强度NTRATER
| Q4 25 | 5.4% | 5.8% | ||
| Q3 25 | 3.8% | 6.1% | ||
| Q2 25 | 4.7% | 7.7% | ||
| Q1 25 | 4.3% | 9.3% | ||
| Q4 24 | 3.8% | 7.6% | ||
| Q3 24 | 3.7% | 7.0% | ||
| Q2 24 | 2.8% | 6.1% | ||
| Q1 24 | 5.5% | 7.3% |
现金转化率NTRATER
| Q4 25 | 1.56× | 1.09× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.11× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTRA
暂无分部数据
TER
| Soc | $646.5M | 60% |
| Memory | $206.5M | 19% |
| Transferred At Point In Time | $90.0M | 8% |
| Universal Robots | $89.4M | 8% |
| IST | $30.5M | 3% |
| Transferred Over Time | $20.5M | 2% |
